OptiNose announces senior management additions

OptiNose has announced three hires for senior management positions, which it says “will help drive the company forward in its mission to introduce new and valuable treatment options to the market utilizing its novel Bi-Directional Breath Powered Delivery Technology.”

The company has hired Ramona Lloyd as VP, Regulatory Affairs & Quality; Sheila Bergey as VP, Operations & Program Management; and Terrence Terifay as Senior VP and Chief Commercial Officer.

OptiNose CEO Peter Miller said, “I am excited to welcome Ramona, Sheila and Terry to OptiNose and to our senior management team. Their combined years of experience and significant strengths in their respective fields will help solidify our position as a specialty pharmaceuticals company and help advance our core pipeline. I am excited to have them on board and believe their collective skills and experience will be highly complementary to the talented group of colleagues already in the company.”

Avanir Pharmaceuticals and OptiNose recently announced that AVP-825, an intranasal sumatriptan delivered by the OptiNose breath powered device met its primary endpoint in a Phase 3b trial.

Read the OptiNose press release.

Share

published on

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA